Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed with results

Key Signals

4 with results86% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (2)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Completed6
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (7)

Research Network

Activity Timeline